{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:53:39Z","timestamp":1761630819852,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"publisher","award":["81371868"],"award-info":[{"award-number":["81371868"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Municipal Administration of Hospitals Incubating Program","award":["PX2016002"],"award-info":[{"award-number":["PX2016002"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ejso.2018.02.210","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T10:37:22Z","timestamp":1519987042000},"page":"771-777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["The impact of primary tumour location in patients undergoing hepatic resection for colorectal liver metastasis"],"prefix":"10.1016","volume":"44","author":[{"given":"Kun","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5084-2802","authenticated-orcid":false,"given":"Da","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Luan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme","family":"Poston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao-Cai","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2018.02.210_bib1","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00000658-200206000-00002","article-title":"Trends in long-term survival following liver resection for hepatic colorectal metastases","volume":"235","author":"Choti","year":"2002","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2018.02.210_bib2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/SLA.0b013e3180603039","article-title":"Hepatic resection for colorectal metastases: value for risk scoring systems?","volume":"246","author":"Zakaria","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2018.02.210_bib3","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jamcollsurg.2009.12.040","article-title":"Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution","volume":"210","author":"House","year":"2010","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.ejso.2018.02.210_bib4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","article-title":"Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases","volume":"230","author":"Fong","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2018.02.210_bib5","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1002\/cncr.26086","article-title":"Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer","volume":"117","author":"Tran","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2018.02.210_bib6","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ijc.30106","article-title":"RAS mutation is a prognostic biomarker in colorectal cancer patients with metastasectomy","volume":"139","author":"Osumi","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejso.2018.02.210_bib7","article-title":"RAS mutation clinical risk score to predict survival after resection of colorectal liver metastases","author":"Brudvik","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2018.02.210_bib8","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/cncr.29129","article-title":"Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease?","volume":"121","author":"Price","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2018.02.210_bib9","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/SLA.0000000000001351","article-title":"Site and Stage of colorectal cancer influence the likelihood and distribution of disease recurrence and post recurrence survival: data from the FACS randomized controlled trial","volume":"263","author":"Pugh","year":"2016","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.ejso.2018.02.210_bib10","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/annonc\/mdx175","article-title":"Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomised trials","volume":"28","author":"Arnold","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2018.02.210_bib11","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1200\/JCO.2017.35.15_suppl.3525","article-title":"Primary tumor location and efficacy of second-line therapy after initial treatment with FOLFIRI in combination with cetuximab or bevacizumab in patients with metastatic colorectal cancer- FIRE-3 (AIOKRK0306)","volume":"35","author":"Modest","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2018.02.210_bib12","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1200\/JCO.2017.35.15_suppl.3503","article-title":"Primary (1\u00b0) tumor location as an independent prognostic marker from molecular features for overall survival (OS) in patients (pts) with\u00a0metastatic colorectal cancer (mCRC): analysis of CALGB\/SWOG 80405 (Alliance)","volume":"35","author":"Venook","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2018.02.210_bib13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/jso.24425","article-title":"The prognostic implications of primary colorectal tumor location on recurrence and overall survival in patients undergoing resection for colorectal liver metastasis","volume":"114","author":"Sasaki","year":"2016","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2018.02.210_bib14","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1200\/JCO.2006.10.5437","article-title":"Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab","volume":"25","author":"Khambata-Ford","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2018.02.210_bib15","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/gutjnl-2011-300865","article-title":"Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum","volume":"61","author":"Yamauchi","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.ejso.2018.02.210_bib16","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/tpj.2014.73","article-title":"Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy","volume":"15","author":"Maus","year":"2015","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.ejso.2018.02.210_bib17","doi-asserted-by":"crossref","first-page":"779","DOI":"10.7326\/0003-4819-113-10-779","article-title":"Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location","volume":"113","author":"Bufill","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejso.2018.02.210_bib18","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1440-1746.2007.04923.x","article-title":"Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology","volume":"23","author":"Nawa","year":"2008","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.ejso.2018.02.210_bib19","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1002\/cncr.28954","article-title":"KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases","volume":"120","author":"Kemeny","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2018.02.210_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.suronc.2014.02.002","article-title":"Controversies in the oncosurgical management of liver limited stage IV colorectal cancer","volume":"23","author":"Jones","year":"2014","journal-title":"Surg Oncol"},{"key":"10.1016\/j.ejso.2018.02.210_bib21","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1056\/NEJMra065156","article-title":"Strategies for safer liver surgery and partial liver transplantation","volume":"356","author":"Clavien","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2018.02.210_bib22","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/annonc\/mds053","article-title":"Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)","volume":"23","author":"Ruers","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2018.02.210_bib23","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.ejca.2013.12.008","article-title":"Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the european organisation for research and treatment of cancer #40004 and #40983","volume":"50","author":"Tanis","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2018.02.210_bib24","article-title":"Prognostic and predictive relevance of primary tumor location in patients with RAS wild-type metastatic colorectal cancer: retrospective analyses of the CRYSTAL and FIRE-3 trials","author":"Tejpar","year":"2016","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2018.02.210_bib25","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/SLA.0000000000002087","article-title":"Embryonic origin of primary colon cancer predicts pathologic response and survival in patients undergoing resection for colon cancer liver metastases","volume":"267","author":"Yamashita","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2018.02.210_bib26","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1053\/j.gastro.2014.05.009","article-title":"CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer","volume":"147","author":"Shiovitz","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejso.2018.02.210_bib27","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-04-2216","article-title":"ERCC1 codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin\/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer","volume":"11","author":"Viguier","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejso.2018.02.210_bib28","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1200\/JCO.2015.63.2497","article-title":"Phase II pilot study of vemurafenib in patients with metastatic BRAF-mutated colorectal cancer","volume":"33","author":"Kopetz","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2018.02.210_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju427","article-title":"Primary tumor location as a prognostic factor in metastatic colorectal cancer","volume":"107","author":"Loupakis","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2018.02.210_bib30","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1200\/JCO.2010.30.1366","article-title":"Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer","volume":"29","author":"Hutchins","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2018.02.210_bib31","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1245\/s10434-008-0015-y","article-title":"Is there a difference in survival between right- versus left-sided colon cancers?","volume":"15","author":"Meguid","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2018.02.210_bib32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/DCR.0b013e3181c703a4","article-title":"Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival","volume":"53","author":"Benedix","year":"2010","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ejso.2018.02.210_bib33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejca.2016.10.007","article-title":"The relevance of primary tumour location in patients with metastatic colorectal cancer: a meta-analysis of first-line clinical trials","volume":"70","author":"Holch","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2018.02.210_bib34","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/bjs.7032","article-title":"Surgical management and outcomes of colorectal cancer liver metastases","volume":"97","author":"Morris","year":"2010","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2018.02.210_bib35","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.ejso.2018.02.210_bib36","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.3748\/wjg.v21.i17.5167","article-title":"Sex- and gender-specific disparities in colorectal cancer risk","volume":"21","author":"Kim","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejso.2018.02.210_bib37","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1245\/s10434-016-5361-6","article-title":"Prognostic implication of KRAS status after hepatectomy for colorectal liver metastases varies according to primary colorectal tumor location","volume":"23","author":"Sasaki","year":"2016","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798318308849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798318308849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:25:32Z","timestamp":1760059532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798318308849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0748798318308849"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2018.02.210","relation":{},"ISSN":["0748-7983"],"issn-type":[{"type":"print","value":"0748-7983"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of primary tumour location in patients undergoing hepatic resection for colorectal liver metastasis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2018.02.210","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}